BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38584226)

  • 1. Analysis of the differential expression of serum miR-21-5p, miR-135-5p, and miR-155-5p by Bifidobacterium triplex viable capsules during the perioperative stage of colorectal cancer.
    Zhang J; Guo J; He R; Li J; Du B; Zhang Y; He R; Cheng H
    Int J Colorectal Dis; 2024 Apr; 39(1):48. PubMed ID: 38584226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of serum miR-30a-5p as a diagnostic and prognostic biomarker in colorectal cancer.
    Sun Y; Yang B; Lin M; Yu H; Chen H; Zhang Z
    Cancer Biomark; 2019; 24(3):299-305. PubMed ID: 30829615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of miR-193a-5p correlates with lymph node metastasis and poor prognosis in colorectal cancer.
    Zhang P; Ji DB; Han HB; Shi YF; Du CZ; Gu J
    World J Gastroenterol; 2014 Sep; 20(34):12241-8. PubMed ID: 25232258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of serum exosomal miR-150-5p is associated with poor prognosis in patients with colorectal cancer.
    Zou SL; Chen YL; Ge ZZ; Qu YY; Cao Y; Kang ZX
    Cancer Biomark; 2019; 26(1):69-77. PubMed ID: 31306108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma microRNA-1207-5p as a Potential Biomarker for Diagnosis and Prognosis of Colorectal Cancer.
    Wang X; Li L; Xiao W; Xu Q
    Clin Lab; 2020 Sep; 66(9):. PubMed ID: 32902212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-675-5p Overexpression Is an Independent Prognostic Molecular Biomarker of Short-Term Relapse and Poor Overall Survival in Colorectal Cancer.
    Christodoulou S; Sotiropoulou CD; Vassiliu P; Danias N; Arkadopoulos N; Sideris DC
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer-associated fibroblasts drive colorectal cancer cell progression through exosomal miR-20a-5p-mediated targeting of PTEN and stimulating interleukin-6 production.
    Ghofrani-Shahpar M; Pakravan K; Razmara E; Amooie F; Mahmoudian M; Heshmati M; Babashah S
    BMC Cancer; 2024 Apr; 24(1):400. PubMed ID: 38561726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression levels of miR-143-3p and -424-5p in colorectal cancer and their clinical significance.
    Sahami-Fard MH; Kheirandish S; Sheikhha MH
    Cancer Biomark; 2019; 24(3):291-297. PubMed ID: 30883340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A panel of serum exosomal microRNAs as predictive markers for chemoresistance in advanced colorectal cancer.
    Jin G; Liu Y; Zhang J; Bian Z; Yao S; Fei B; Zhou L; Yin Y; Huang Z
    Cancer Chemother Pharmacol; 2019 Aug; 84(2):315-325. PubMed ID: 31089750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression level of miR-383-5p in colorectal cancer patients following neoadjuvant chemotherapy and its clinical significance in the prognosis.
    Sun X; Wang X; Dong G; Zhao Z; Song J
    Minerva Med; 2023 Aug; 114(4):485-490. PubMed ID: 32700862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A panel of seven-miRNA signature in plasma as potential biomarker for colorectal cancer diagnosis.
    Zhang H; Zhu M; Shan X; Zhou X; Wang T; Zhang J; Tao J; Cheng W; Chen G; Li J; Liu P; Wang Q; Zhu W
    Gene; 2019 Mar; 687():246-254. PubMed ID: 30458288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of miR-195-5p as a novel prognostic biomarker for colorectal cancer.
    Bayat A; Raad M; Sharafshah A; Ahmadvand M; Aminian H
    Mol Biol Rep; 2022 Jul; 49(7):6453-6457. PubMed ID: 35587844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-6869-5p acts as a tumor suppressor via targeting TLR4/NF-κB signaling pathway in colorectal cancer.
    Yan S; Liu G; Jin C; Wang Z; Duan Q; Xu J; Xu D
    J Cell Physiol; 2018 Sep; 233(9):6660-6668. PubMed ID: 29206292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miRNA-99b-5p suppresses liver metastasis of colorectal cancer by down-regulating mTOR.
    Li W; Chang J; Wang S; Liu X; Peng J; Huang D; Sun M; Chen Z; Zhang W; Guo W; Li J
    Oncotarget; 2015 Sep; 6(27):24448-62. PubMed ID: 26259252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-340-5p is a potential prognostic indicator of colorectal cancer and modulates ANXA3.
    Yang L; Men WL; Yan KM; Tie J; Nie YZ; Xiao HJ
    Eur Rev Med Pharmacol Sci; 2018 Aug; 22(15):4837-4845. PubMed ID: 30070320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and biological significance of miR-378a-3p and miR-378a-5p in colorectal cancer.
    Li H; Dai S; Zhen T; Shi H; Zhang F; Yang Y; Kang L; Liang Y; Han A
    Eur J Cancer; 2014 Apr; 50(6):1207-21. PubMed ID: 24412052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating Plasma Levels of miR-20b, miR-29b and miR-155 as Predictors of Bevacizumab Efficacy in Patients with Metastatic Colorectal Cancer.
    Ulivi P; Canale M; Passardi A; Marisi G; Valgiusti M; Frassineti GL; Calistri D; Amadori D; Scarpi E
    Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29361687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-96-5p influences cellular growth and is associated with poor survival in colorectal cancer patients.
    Ress AL; Stiegelbauer V; Winter E; Schwarzenbacher D; Kiesslich T; Lax S; Jahn S; Deutsch A; Bauernhofer T; Ling H; Samonigg H; Gerger A; Hoefler G; Pichler M
    Mol Carcinog; 2015 Nov; 54(11):1442-50. PubMed ID: 25256312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-140-5p inhibits the progression of colorectal cancer by targeting VEGFA.
    Zhang W; Zou C; Pan L; Xu Y; Qi W; Ma G; Hou Y; Jiang P
    Cell Physiol Biochem; 2015; 37(3):1123-33. PubMed ID: 26402430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-378a-5p inhibits the proliferation of colorectal cancer cells by downregulating CDK1.
    Li K; Zhang J; Zhang M; Wu Y; Lu X; Zhu Y
    World J Surg Oncol; 2021 Feb; 19(1):54. PubMed ID: 33608020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.